En Es
Categories

Industry News


Stago Connect.One Network Allows Remote Monitoring of Analyzers

By Labmedica International staff writers
09 Aug 2018

Image: The Connect.One network architecture allows labs to remotely monitor automated analyzers (Photo courtesy of Diagnostica Stago).Diagnostica Stago (Paris, France), an in-vitro diagnostics company focusing on thrombosis and hemostasis, has launched the secure Connect.One network architecture, which allows laboratories to benefit from remote monitoring of their automated analyzers.

Stago offers laboratories advanced testing systems and services with specialization in hemostasis and hemostasis systems, in-vitro diagnostics, routine and specialty reagents, and research products. Digitization has revolutionized connectivity by increasing productivity and improving lab efficiency. Today, with connected devices, technical teams are no longer required to remain in front of their workstations, or even in the laboratory.

Stago’s Connect.One checks if automated analyzers in laboratories are operating correctly and diagnoses and analyzes any malfunctions as part of a proactive approach. Systems connected to Connect.One can send QC results to MyExpertQC (Stago’s externalized IQC platform), as well as activity statistics to simplify the management of “Cost Per Reportable Results” contracts. Connect.One can track analyzer performance and send notifications in case of problems while downloading software improvements from a secure infrastructure.

Connect.One is designed to meet international data privacy and security guidelines, and is expected to become a “cornerstone” for integrating new applications. By using their connected devices, laboratories can increase productivity, efficiency and operational flexibility.



E-mail Print
FaceBook Twitter Google+ Linked in

DIAGNOSTICA STAGO

Offers a complete system of hemostasis instrumentation and optimized reagent kits for research, as well as for routine analysis
Gold member
More info

More articles about DIAGNOSTICA STAGO

30 May 2017
Stago Group Acquires HemoSonics
The Stago Group, which develops and markets automated systems for blood analysis in coagulation, has completed the acquisition of HemoSonics LLC, a developer of point-of-care (POC) testing solutions.
Read More

Additional news

23 Nov 2018
AI Predicts Alzheimer’s Disease Years before Diagnosis
A new study on the application of deep learning (DL) to detect changes in brain metabolism predictive of Alzheimer’s disease (AD) has found that artificial intelligence (AI) improves the ability of brain imaging to predict AD.
Read More
23 Nov 2018
UK to Set Up New GBP 10 Million Centre for Medical Imaging and AI
The UK’s London Medical Imaging & Artificial Intelligence Centre for Value-Based Healthcare will train sophisticated artificial intelligence (AI) algorithms from NHS medical images and patient data, to create tools that will help clinicians speed up and improve diagnosis and care across a number of patient pathways, including dementia, heart failure and cancer.
Read More
23 Nov 2018
New AI Algorithm Enhances Polyp Detection in Colonoscopy Procedures
Researchers at Shanghai Wision AI Co., Ltd., a developer of computer-aided diagnostic algorithms and systems to improve the accuracy and effectiveness of diagnostic imaging, have announced results of a study validating a novel machine-learning algorithm that improves detection of adenomatous polyps during colonoscopy. The AI algorithm is built on the same network architecture that is used to develop self-driving cars and is designed to enable “self-driving” in colonoscopy procedures.
Read More
20 Nov 2018
Study Finds AI Falls Short When Analyzing Medical Data
A study conducted at the Icahn School of Medicine at Mount Sinai has found that artificial intelligence (AI) tools trained to detect pneumonia on chest X-rays suffered significant decreases in performance when tested on data from outside health systems. These findings suggest that unless AI in the medical space is carefully tested for performance across a wide range of populations, the deep learning models may not perform as accurately as expected.
Read More
20 Nov 2018
New AI Software for Brain Bleed Diagnosis Receives FDA Clearance
The US Food and Drug Administration (FDA) has given 510(k) clearance to the Accipio Ix intracranial hemorrhage (ICH) detection software developed by MaxQ AI, a clinical diagnostics intelligence platform company.
Read More
20 Nov 2018
Global Refurbished Medical Devices Market to Increase by 10% by 2023
The global refurbished medical devices market is expected to grow at a CAGR of over 10% during the forecast period 2019-2023, driven by the organized healthcare ecosystem in the developed economies. Moreover, privatization in the healthcare sector is increasing rapidly due to the inability of governments to invest efficiently in the sector, coupled with high demand for innovation and technology for superior healthcare services.
Read More
12 Nov 2018
ACR Data Science Institute Releases AI Use Cases to Accelerate AI Adoption
The American College of Radiology Data Science Institute has released a first-of-its-kind series of standardized artificial intelligence (AI) use cases that will accelerate medical imaging AI adoption. This continually updated, freely available use case series is the product of a previously missing and collaborative framework that enables efficient creation, implementation and ongoing improvement of radiological AI tools.
Read More
12 Nov 2018
Siemens Healthineers and Primary Health Care Enter Contract for In Vitro Diagnostics
Siemens Healthineers has entered into a strategic partnership with Australian integrated healthcare provider Primary Health Care to deploy more than 70 Atellica Solution immunoassay and clinical chemistry analyzers, marking the largest contract ever for in vitro diagnostics testing in the country.
Read More
12 Nov 2018
OpenSight Augmented Reality System for Microsoft HoloLens Cleared by FDA
The FDA has granted 510(k) clearance to the OpenSight Augmented Reality System, making it the first AR medical solution for Microsoft HoloLens to be cleared for use in pre-operative surgical planning. Developed by Novarad, a provider of specialized enterprise imaging and workflow solutions, OpenSight renders 2D, 3D and 4D images of patients interactively, while accurately overlaying them directly onto the patient’s body.
Read More
Copyright © 2000-2018 TradeMed.com. All rights reserved. | Terms And Conditions